Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.92B 3.24B 2.83B 2.61B 2.4B 4.55B 312B 4.63B 31.18B 12.23B 152B 12.16B 11.89B 525B P/E 2026 *
14.8x
P/E 2027 * 12.8x
Enterprise Value 18.4B 2.72B 2.38B 2.19B 2.02B 3.82B 262B 3.88B 26.17B 10.27B 128B 10.21B 9.98B 441B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.54x
Free-Float
34.77%
Yield 2026 *
4.68%
Yield 2027 * 5.16%
1 day-2.18%
1 week+10.13%
Current month+28.08%
1 month+12.05%
3 months+12.84%
6 months+2.72%
Current year+9.25%
1 week 17.36
Extreme 17.36
19.96
1 month 14.39
Extreme 14.39
19.96
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.18%+10.13%+10.89%-29.10% 3.31B
+1.52%+0.54%-17.27%-31.72% 15.05B
+1.82%-3.45%-26.48%-35.26% 6.81B
+0.28%-0.72%-21.34%-6.62% 5.95B
+0.52%+6.40%-11.65%-29.93% 3.82B
-0.33%-3.29%-30.07%-48.09% 3.16B
+3.36%+0.01%-37.82%-12.38% 3.12B
+0.76%-1.04%+94.50% - 2.51B
+1.56%-2.25%-19.40%-1.72% 2.48B
0.00%+0.87%+0.90%+35.19% 1.7B
Average +0.72%+1.34%-5.77%-17.74% 4.79B
Weighted average by Cap. +0.97%+1.49%-12.48%-24.28%

Financials

2026 *2027 *
Net sales 29.91B 4.42B 3.86B 3.56B 3.27B 6.2B 425B 6.31B 42.53B 16.69B 208B 16.59B 16.22B 716B 33.03B 4.88B 4.27B 3.93B 3.62B 6.85B 469B 6.97B 46.98B 18.43B 229B 18.32B 17.92B 791B
Net income 1.48B 219M 192M 177M 163M 308M 21.1B 313M 2.11B 828M 10.31B 823M 805M 35.54B 1.71B 253M 221M 204M 188M 356M 24.37B 362M 2.44B 957M 11.91B 951M 930M 41.05B
Net Debt -3.52B -520M -454M -419M -385M -730M -50.01B -743M -5B -1.96B -24.45B -1.95B -1.91B -84.26B -4.01B -592M -518M -478M -439M -832M -56.99B -846M -5.7B -2.24B -27.85B -2.22B -2.18B -96B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
15/07/26 CN¥19.25 -2.18% 17,979,224
14/07/26 CN¥19.68 +8.85% 19,782,719
13/07/26 CN¥18.08 +2.44% 8,920,661
10/07/26 CN¥17.65 0.00% 7,824,491
09/07/26 CN¥17.65 -0.90% 7,836,718
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
19.25CNY
Average target price
24.70CNY
Spread / Average Target
+28.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock